Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.
about
Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis.Beta-lactamase-producing enterococci.Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditisTreatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactamSuccessful trovafloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.Linezolid in prophylaxis against experimental aortic valve endocarditis due to Streptococcus oralis or Enterococcus faecalis.Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitroAmpicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats.Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strainsEfficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis.
P2860
Q33595252-FBF2FD6F-E365-4FE7-8923-FDF95E8F31EAQ33744784-6E87C099-A4A4-41A9-91F1-D736DFD204DAQ33748332-36FAA893-AB7F-48EF-AA33-F34A06E980F9Q33977947-8043AF27-F6D8-40B5-84E9-6A5D73996066Q33980637-F418079F-D1ED-47F3-A1E4-6EA4F1788A3CQ34352123-65512721-9265-4C94-9E6F-E5BB08F48E73Q34534007-EE2029B3-F19A-4C3C-9D30-025D6F156B5AQ35121661-68D3C197-7110-4C46-8E70-02338B268CB3Q35138023-074C8ACA-86F5-420E-809E-9EF926BAB979Q35759063-3447E6AF-3044-4D18-9E3C-1F7F39A66BC0Q35823261-76395744-6E9A-4C65-B0B2-FA4B2F2085DDQ35896915-B92EFEAF-8930-40EE-961E-F3198E0BB644Q36753343-850C2AD7-8926-4C88-8FAA-3C67E44F997AQ39558119-61AF3219-245A-4E35-A290-94E1E45DBF7FQ39781489-2DC503F9-E842-4BBB-A10D-7E5CE97CE8D9Q39781738-9F54D9B0-EAE6-4C7E-BD85-56E6FCEBF909
P2860
Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Chemoprophylactic efficacy aga ...... ged serum inhibitory activity.
@en
Chemoprophylactic efficacy aga ...... ged serum inhibitory activity.
@nl
type
label
Chemoprophylactic efficacy aga ...... ged serum inhibitory activity.
@en
Chemoprophylactic efficacy aga ...... ged serum inhibitory activity.
@nl
prefLabel
Chemoprophylactic efficacy aga ...... ged serum inhibitory activity.
@en
Chemoprophylactic efficacy aga ...... ged serum inhibitory activity.
@nl
P2860
P356
P1476
Chemoprophylactic efficacy aga ...... ged serum inhibitory activity.
@en
P2860
P304
P356
10.1128/AAC.34.6.1068
P407
P577
1990-06-01T00:00:00Z